中国组织工程研究 ›› 2023, Vol. 27 ›› Issue (33): 5377-5384.doi: 10.12307/2023.716
• 干细胞综述 stem cell review • 上一篇 下一篇
王绍娜1,刘飞祥1,2,应春苗1,高 晨1,张运克1,2
收稿日期:
2022-10-11
接受日期:
2022-11-18
出版日期:
2023-11-28
发布日期:
2023-03-30
通讯作者:
张运克,汉族,教授,主任医师,博士生导师,博士后合作导师,河南中医药大学,河南省郑州市 450000;河南中医药大学第一附属医院,河南省郑州市 450000
作者简介:
王绍娜,女,1996 年生,河南省郑州市人,汉族,河南中医药大学在读硕士,主要从事中医药防治神经系统疾病的研究。
基金资助:
Wang Shaona1, Liu Feixiang1, 2, Ying Chunmiao1, Gao Chen1, Zhang Yunke1, 2
Received:
2022-10-11
Accepted:
2022-11-18
Online:
2023-11-28
Published:
2023-03-30
Contact:
Zhang Yunke, Professor, Chief physician, Doctoral supervisor, Henan University of Chinese Medicine, Zhengzhou 450000, Henan Province, China; First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, Henan Province, China
About author:
Wang Shaona, Master candidate, Henan University of Chinese Medicine, Zhengzhou 450000, Henan Province, China
Supported by:
摘要:
文题释义:
骨髓间充质干细胞:是存在于骨髓中具备多向分化能力的多能干细胞,具有来源丰富、培养简单、分化速度快、低排斥性等优势,常作为修复神经系统损伤和基因工程的理想种子细胞。结果与结论:①梳理了血脑屏障的生理结构与脑缺血再灌注损伤发生后血脑屏障结构的病理变化;②总结了中药联合骨髓间充质干细胞调控脑缺血再灌注损伤后血脑屏障的机制:包括调控紧密连接蛋白表达、抑制水通道蛋白4、基质金属蛋白酶9活性、促进血管新生、抑制炎性递质释放、调控外泌体;③总结发现中药联合骨髓间充质干细胞能改善受损血脑屏障通透性,为临床治疗效果提供辅助。
https://orcid.org/0000-0003-1500-1535 (张运克)
中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程
中图分类号:
王绍娜, 刘飞祥, 应春苗, 高 晨, 张运克. 中药联合骨髓间充质干细胞调控脑缺血再灌注损伤后血脑屏障的作用机制[J]. 中国组织工程研究, 2023, 27(33): 5377-5384.
Wang Shaona, Liu Feixiang, Ying Chunmiao, Gao Chen, Zhang Yunke. Action mechanism of traditional Chinese medicine combined with bone marrow mesenchymal stem cells in regulating blood-brain barrier after cerebral ischemia reperfusion injury[J]. Chinese Journal of Tissue Engineering Research, 2023, 27(33): 5377-5384.
[1] OTERO-ORTEGA L, LASO-GARCÍA F, GÓMEZ-DE FRUTOS M, et al. Role of Exosomes as a Treatment and Potential Biomarker for Stroke. Transl Stroke Res. 2019;10(3):241-249. [2] THRIFT AG, HOWARD G, CADILHAC DA, et al. Global stroke statistics: An update of mortality data from countries using a broad code of “cerebrovascular diseases”. Int J Stroke. 2017;12(8): 796-801. [3] YARYGIN KN, NAMESTNIKOVA DD, SUKHINICH KK, et al. Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood-Brain Barrier? Cells. 2021; 10(11):2997. [4] LALU MM, MONTROY J, DOWLATSHAHI D, et al. From the Lab to Patients: a Systematic Review and Meta-Analysis of Mesenchymal Stem Cell Therapy for Stroke. Transl Stroke Res. 2020; 11(3):345-364. [5] 刘抒雯,杨丽华,马春,等.中医药保护脑缺血再灌注损伤后神经血管单元的作用[J].中国实验方剂学杂志,2018,24(23):225-234. [6] SWEENEY MD, SAGARE AP, ZLOKOVIC BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nature Rev Neurol. 2018;14(3):133-150. [7] JIA W, LU R, MARTIN TA, et al. The role of claudin-5 in blood-brain barrier (BBB) and brain metastases (review). Mol Med Rep. 2014;9(3):779-785. [8] SWEENEY MD, AYYADURAI S, ZLOKOVIC BV. Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci. 2016;19(6):771-783. [9] LV J, HU W, YANG Z, et al. Focusing on claudin-5: A promising candidate in the regulation of BBB to treat ischemic stroke. Prog Neurobiol. 2018;161:79-96. [10] LIAO Z, YANG Z, PIONTEK A, et al. Specific binding of a mutated fragment of Clostridium perfringens enterotoxin to endothelial claudin- 5 and its modulation of cerebral vascular permeability. Neuroscience. 2016;327:53-63. [11] DIAZ R, MIGUEL PM, DENIZ BF, et al. Environmental enrichment attenuates the blood brain barrier dysfunction induced by the neonatal hypoxia- ischemia. Int J Dev Neurosci. 2016;53:35-45. [12] 张楠.王思迪.涂盼春.等.紧密连接相关蛋白对血脑屏障通透性影响的研究进展[J].沈阳医学院学报,2017,19(1):72-75. [13] XIONG R, ZHOU XG, TANG Y, et al. Lychee seed polyphenol protects the blood-brain barrier through inhibiting Aβ(25-35)-induced NLRP3 inflammasome activation via the AMPK/mTOR/ULK1-mediated autophagy in bEnd.3 cells and APP/PS1 mice. Phytother Res. 2021;35(2):954-973. [14] NIKOLAKOPOULOU AM, ZHAO Z, MONTAGNE A, et al. Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-β signaling. PLoS One. 2017;12(4):e0176225. [15] ALVAREZ JI, DODELET-DEVILLERS A, KEBIR H, et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science. 2011;334(6063):1727-1731. [16] OBERMEIER B, DANEMAN R, RANSOHOFF RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19(12):1584-1596. [17] MA Y, YANG X, CHATTERJEE V, et al. Role of Neutrophil Extracellular Traps and Vesicles in Regulating Vascular Endothelial Permeability. Front Immunol. 2019;10:1037. [18] QIU YM, ZHANG CL, CHEN AQ, et al. Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy? Front Immunol. 2021;12:678744. [19] ZHAO Y, GAN L, REN L, et al. Factors influencing the blood-brain barrier permeability. Brain Res. 2022;1788:147937. [20] CHEN R, SONG Z, DENG M, et al. TIMP-2 Polymorphisms Define Subtypes of Hypertensive Intracerebral Hemorrhage with Distinct Perihematomal Edema Development Patterns. Curr Neurovasc Res. 2020;17(1):44-49. [21] KATADA R, AKDEMIR G, ASAVAPANUMAS N, et al. Greatly improved survival and neuroprotection in aquaporin-4-knockout mice following global cerebral ischemia. FASEB J. 2014;28(2):705-714. [22] SHEN Y, GU J, LIU Z, et al. Inhibition of HIF-1α Reduced Blood Brain Barrier Damage by Regulating MMP-2 and VEGF During Acute Cerebral Ischemia. Front Cell Neurosci. 2018;12:288. [23] MICHINAGA S, KIMURA A, HATANAKA S, et al. Delayed Administration of BQ788, an ETB Antagonist, after Experimental Traumatic Brain Injury Promotes Recovery of Blood-Brain Barrier Function and a Reduction of Cerebral Edema in Mice. J Neurotrauma. 2018;35(13):1481-1494. [24] 张伟,吴晓丹,刘海旭,等.中医药对缺血性中风后血脑屏障保护作用的研究进展[J].中国医药,2021,16(1):149-152. [25] SALMINA AB, KHARITONOVA EV, GORINA YV, et al. Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration. Int J Mol Sci. 2021;22(9):4661. [26] 苏晓梅,张丹参.细胞间线粒体转移治疗缺血性脑卒中研究进展[J].中国药理学与毒理学杂志,2021,35(6):462-470. [27] LEE MJ, JANG Y, HAN J, et al. Endothelial-specific Crif1 deletion induces BBB maturation and disruption via the alteration of actin dynamics by impaired mitochondrial respiration. J Cereb Blood Flow Metab. 2020;40(7):1546-1561. [28] DUPONT M, SOURIANT S, LUGO-VILLARINO G, et al. Tunneling Nanotubes: Intimate Communication between Myeloid Cells. Front Immunol. 2018;9:43. [29] PISANI F, CASTAGNOLA V, SIMONE L, et al. Role of pericytes in blood-brain barrier preservation during ischemia through tunneling nanotubes. Cell Death Dis. 2022;13(7):582. [30] LIU K, JI K, GUO L, et al. Mesenchymal stem cells rescue injured endothelial cells in an in vitro ischemia-reperfusion model via tunneling nanotube like structure-mediated mitochondrial transfer. Microvasc Res. 2014;92:10-18. [31] LIU K, GUO L, ZHOU Z, et al. Mesenchymal stem cells transfer mitochondria into cerebral microvasculature and promote recovery from ischemic stroke. Microvasc Res. 2019;123:74-80. [32] SHEIKH MH, SOLITO E. Annexin A1: Uncovering the Many Talents of an Old Protein. Int J Mol Sci. 2018;19(4):1045. [33] CRISTANTE E, MCARTHUR S, MAURO C, et al. Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc Natl Acad Sci U S A. 2013;110(3):832-841. [34] PARK JC, BAIK SH, HAN SH, et al. Annexin A1 restores Aβ1-42 -induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway. Aging Cell. 2017;16(1):149-161. [35] GUSSENHOVEN R, KLEIN L, OPHELDERS DRMG, et al. Annexin A1 as Neuroprotective Determinant for Blood-Brain Barrier Integrity in Neonatal Hypoxic-Ischemic Encephalopathy. J Clin Med. 2019;8(2):137. [36] TANG G, LIU Y, ZHANG Z, et al. Mesenchymal stem cells maintain blood-brain barrier integrity by inhibiting aquaporin-4 upregulation after cerebral ischemia. Stem Cells. 2014;32(12):3150-3162. [37] KIM R, KIM P, LEE CY, et al. Multiple Combination of Angelica gigas Extract and Mesenchymal Stem Cells Enhances Therapeutic Effect. Biol Pharm Bull. 2018;41(12):1748-1756. [38] 刘敬霞,任非非,刘会贤,等.回药扎里奴思方联合BMSCs移植对脑缺血再灌注大鼠BBB紧密连接蛋白的影响[J].中风与神经疾病杂志,2016,33(1):54-59. [39] 张运克,车志英,李可.补阳还五汤联合骨髓间充质干细胞移植脑缺血再灌注大鼠脑组织紧密连接蛋白的表达[J].中国组织工程研究,2019,23(1):55-60. [40] LISJAK M, POTOKAR M, RITUPER B, et al. AQP4e-Based Orthogonal Arrays Regulate Rapid Cell Volume Changes in Astrocytes. J Neurosci. 2017;37(44):10748-10756. [41] 祝连明.益母草碱对缺血性脑损伤大鼠脑组织抗氧化应激及AQP4蛋白表达的影响[J].内蒙古中医药,2018,37(11):96-97. [42] DATTA A, SARMAH D, KAUR H, et al. Post-stroke Impairment of the Blood-Brain Barrier and Perifocal Vasogenic Edema Is Alleviated by Endovascular Mesenchymal Stem Cell Administration: Modulation of the PKCδ/MMP9/AQP4-Mediated Pathway. Mol Neurobiol. 2022;59(5):2758-2775. [43] 刘旋辉,容鹏飞,黄远桃,等.丁苯酞对脑缺血再灌注大鼠AQP4和MMP9表达及磁共振扩散成像的影响[J].老年医学与保健,2019, 25(5):605-609+632. [44] TANG Y, SOROUSH F, SUN S, et al. Protein kinase C-delta inhibition protects blood-brain barrier from sepsis-induced vascular damage. J Neuroinflammation. 2018;15(1):309. [45] HSIEH HL, WU CY, YANG CM. Bradykinin induces matrix metalloproteinase-9 expression and cell migration through a PKC-delta-dependent ERK/Elk-1 pathway in astrocytes. Glia. 2008; 56(6):619-632. [46] CHOU WH, MESSING RO. Hypertensive encephalopathy and the blood-brain barrier: is deltaPKC a gatekeeper? J Clin Invest. 2008;118(1):17-20. [47] LOZITO TP, TUAN RS. Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol. 2011;226(2): 385-396. [48] YANG P, TIAN YM, DENG WX, et al. Sijunzi decoction may decrease apoptosis via stabilization of the extracellular matrix following cerebral ischaemia-reperfusion in rats. Exp Ther Med. 2019;18(4):2805-2812. [49] 涂华,胡光强,陈碧琼,等.栀子苷预处理对脑缺血再灌注大鼠血脑屏障的保护作用[J].中风与神经疾病杂志,2015,32(6):508-510. [50] LI JS, LIU JX, SUN J, et al. Effects of rhubarb aglycone on matrix metalloproteinase in cerebral ischemic tissue in rats with bone marrow mesenchymal stem cell transplantation. Zhong Xi Yi Jie He Xue Bao. 2008;6(8):810-816. [51] CHENG Z, WANG L, QU M, et al. Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice. J Neuroinflammation. 2018;15(1):135. [52] WANG C, BÖRGER V, SARDARI M, et al. Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils. Stroke. 2020; 51(6):1825-1834. [53] 汤光辉.骨髓间充质干细胞抑制水通道蛋白4的上调减轻脑缺血诱发的脑水肿的分子机理研究[D].上海:上海交通大学,2014. [54] 孙捷.脑脉通联合骨髓间充质干细胞移植对脑缺血再灌注大鼠微血管损伤的保护作用[D].郑州:河南中医学院,2007. [55] GREENBERG DA, JIN K. Vascular endothelial growth factors (VEGFs) and stroke. Cell Mol Life Sci. 2013;70(10):1753-1761. [56] ZHENG H, LIU C, OU Y, et al. Total saponins of Panax notoginseng enhance VEGF and relative receptors signals and promote angiogenesis derived from rat bone marrow mesenchymal stem cells. J Ethnopharmacol. 2013;147(3):595-602. [57] ZHANG ZG, ZHANG L, JIANG Q, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest. 2000;106(7):829-838. [58] VALABLE S, MONTANER J, BELLAIL A, et al. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. J Cereb Blood Flow Metab. 2005;25(11):1491-1504. [59] ZHANG HT, ZHANG P, GAO Y, et al. Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs. Mol Med Rep. 2017; 15(1):57-64. [60] KIKUCHI-TAURA A, OKINAKA Y, SAINO O, et al. Gap junction-mediated cell-cell interaction between transplanted mesenchymal stem cells and vascular endothelium in stroke. Stem Cells. 2021;39(7):904-912. [61] 王延,钱海兵. Ang-1/Tie-2信号通路与缺血性脑卒中的相关性研究述评[J].中国中医基础医学杂志,2021,27(1):170-172,177. [62] 春花,黄骥翀,赵凤艳,等.血管生成素2对血脑屏障的调控作用与相关机制研究[J].高原科学研究,2022,6(1):76-81. [63] DU J, YIN G, HU Y, et al. Coicis semen protects against focal cerebral ischemia-reperfusion injury by inhibiting oxidative stress and promoting angiogenesis via the TGFβ/ALK1/Smad1/5 signaling pathway. Aging (Albany NY). 2020;13(1):877-893. [64] LI L, CHU L, REN C, et al. Enhanced Migration of Bone Marrow-Derived Mesenchymal Stem Cells with Tetramethylpyrazine and Its Synergistic Effect on Angiogenesis and Neurogenesis After Cerebral Ischemia in Rats. Stem Cells Dev. 2019;28(13):871-881. [65] 秦红玲,农必华,陈炜,等.清热化瘀方联合骨髓间充质干细胞移植对脑缺血再灌注损伤大鼠血管新生的影响[J].现代中西医结合杂志,2017,26(25):2747-2750. [66] 陈朝.脑脉一号联合骨髓间充质干细胞移植对缺血中风大鼠脑微血管生成的影响[D].广州:广州中医药大学,2010. [67] 王燃冰,胡红艳,刘颖,等.益气活血类中药及骨髓间充质干细胞对脑血管新生相关血管内皮生长因子及其受体影响的研究进展[J].中医临床研究,2015,7(4):144-145+148. [68] 周瑸,于筠,袁鲁,等.灯盏花素联合骨髓间充质干细胞治疗鼠脑梗塞模型的研究[C].上海:中国中西医结合学会神经外科专业委员会第四届学术大会论文集,2017. [69] 张运克,高峰,张丹,等.补阳还五汤联合骨髓间充质干细胞移植对脑缺血再灌注大鼠脑组织NSE和GFAP表达的影响[J].中医杂志,2013,54(23):2043-2045. [70] 李艳玲,丁煌,杨芙蓉,等.黄芪甲苷配伍三七总皂苷对脑缺血大鼠BMSCs移植后血管新生的影响[J].中国实验方剂学杂志,2021,27(21):73-79. [71] HUANG Y, WANG J, CAI J, et al. Targeted homing of CCR2-overexpressing mesenchymal stromal cells to ischemic brain enhances post-stroke recovery partially through PRDX4-mediated blood-brain barrier preservation. Theranostics. 2018;8(21):5929-5944. [72] CHEN X, LIANG H, XI Z, et al. BM-MSC Transplantation Alleviates Intracerebral Hemorrhage-Induced Brain Injury, Promotes Astrocytes Vimentin Expression, and Enhances Astrocytes Antioxidation via the Cx43/Nrf2/HO-1 Axis. Front Cell Dev Biol. 2020;8:302. [73] ZHOU F, WANG M, JU J, et al. Schizandrin A protects against cerebral ischemia-reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK/Nrf2 pathway regulation. Am J Transl Res. 2019;11(1):199-209. [74] 张昊悦,赵蓓,王业皇,等.大黄素通过调节Nrf2/HO-1和MAPKs抑制炎症和氧化应激机制研究[J].中国免疫学杂志,2021,37(9): 1063-1068. [75] MAO L, YANG T, LI X, et al. Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway. J Cereb Blood Flow Metab. 2019;39(2):352-366. [76] 黄锦龙,李宸,杨亮亮,等.脑缺血再灌注小鼠M1极化的小胶质细胞分泌的可溶性Robo4对血脑屏障完整性的破坏作用[J].生理学报,2022,74(4):513-524. [77] LIU X, CHEN X, ZHU Y, et al. Effect of magnolol on cerebral injury and blood brain barrier dysfunction induced by ischemia-reperfusion in vivo and in vitro. Metab Brain Dis. 2017;32(4): 1109-1118. [78] CAO G, JIANG N, HU Y, et al. Ruscogenin Attenuates Cerebral Ischemia-Induced Blood-Brain Barrier Dysfunction by Suppressing TXNIP/NLRP3 Inflammasome Activation and the MAPK Pathway. Int J Mol Sci. 2016;17(9):1418. [79] 靳晓飞,张彐宁,周晓红,等.黄芪甲苷对脑缺血再灌注大鼠炎症因子及超微结构的影响[J].中国比较医学杂志,2020,30(4):1-6. [80] 郑娜.补肾中药有效成分对小胶质细胞极化的调节及机制研究[D].广州:广州中医药大学,2017. [81] 刘雪.铁皮石斛多糖对骨髓间充质干细胞向神经样细胞分化及MCAO模型大鼠预后的影响[D].合肥:安徽医科大学,2020. [82] 李祺,王秀,杜丽娜.外泌体在脑靶向递送中的应用[J].药学学报,2022,57(3):658-669. [83] GE X, LI W, HUANG S, et al. Increased miR-21-3p in Injured Brain Microvascular Endothelial Cells after Traumatic Brain Injury Aggravates Blood-Brain Barrier Damage by Promoting Cellular Apoptosis and Inflammation through Targeting MAT2B. J Neurotrauma. 2019;36(8):1291-1305. [84] GE X, HUANG S, GAO H, et al. miR-21-5p alleviates leakage of injured brain microvascular endothelial barrier in vitro through suppressing inflammation and apoptosis. Brain Res. 2016; 1650:31-40. [85] KALANI A, KAMAT PK, FAMILTSEVA A, et al. Role of microRNA29b in blood-brain barrier dysfunction during hyperhomocysteinemia: an epigenetic mechanism. J Cereb Blood Flow Metab. 2014;34(7):1212-1222. [86] WANG Y, HUANG J, MA Y, et al. MicroRNA-29b is a therapeutic target in cerebral ischemia associated with aquaporin 4. J Cereb Blood Flow Metab. 2015;35(12):1977-1984. [87] 郝磊,金戈,杨涌涛,等.骨髓间充质干细胞外泌体介导miR-124-1对小胶质细胞M2型极化调控的影响[J].上海交通大学学报(医学版),2022,42(3):323-330. [88] HE R, JIANG Y, SHI Y, et al. Curcumin-laden exosomes target ischemic brain tissue and alleviate cerebral ischemia-reperfusion injury by inhibiting ROS-mediated mitochondrial apoptosis. Mater Sci Eng C Mater Biol Appl. 2020;117:111314. [89] 姜萌萌.芎归方协同BMSCs-exosomes干预脑卒中神经炎症的效应研究[D].天津:天津中医药大学,2021. [90] 白晓丹.芎归方协同BMSCs-exosomes干预缺血性脑损伤神经重塑的作用研究[D].天津:天津中医药大学,2020. [91] CHEN L, LI Y, CHEN W, et al. Enhanced recruitment and hematopoietic reconstitution of bone marrow-derived mesenchymal stem cells in bone marrow failure by the SDF-1/CXCR4. J Tissue Eng Regen Med. 2020;14(9):1250-1260. [92] 胡跃强,陈海峰,甘业贤,等.缺氧预处理MSCs移植对脑缺血再灌注损伤大鼠SDF-1/CXCR4表达的影响及清热化瘀方的干预作用[J].中药新药与临床药理,2016,27(6):779-784. [93] 陆吴超,钱伟宏,姚志宏,等.补肾、活血中药及补肾活血复方对骨髓间充质干细胞增殖、定向迁移及成骨分化的影响及作用机制的研究进展[J].中医正骨,2018,30(7):36-38. [94] 李琳.川芎嗪预处理促进骨髓间充质干细胞向损伤区迁移提高脑缺血的治疗作用[D].杭州:浙江中医药大学,2015. [95] 曲铁兵.川芎嗪预处理促进骨髓间充质干细胞迁移的体外研究[D].杭州:浙江中医药大学,2014. [96] 汪禹,陈铁龙,梁翠,等.黄芪甲苷提高骨髓间充质干细胞缺氧微环境下耐受性的作用机制研究[J].中国现代应用药学,2021,38(7): 814-819. [97] 包翠芬,包翠芳,李磊,等.人参皂苷Rg1联合BMSCs对大鼠脑缺血再灌注损伤的保护作用[J].山东医药,2012,52(25):9-11. |
[1] | 农复香, 蒋志雄, 李英豪, 许文聪, 施智兰, 罗 慧, 张晴朗, 钟 爽, 唐梅文. 外泌体调控铁死亡在疾病诊断治疗中的应用与作用[J]. 中国组织工程研究, 2023, 27(在线): 1-10. |
[2] | 潘钟杰, 秦志鸿, 郑铁军, 丁晓飞, 廖世杰. 股骨头坏死发病机制中非编码RNA的靶标性[J]. 中国组织工程研究, 2023, 27(9): 1441-1447. |
[3] | 蔡志浩, 谢召勇. 股骨颈前倾角测量评估:如何建立统一的方法和标准[J]. 中国组织工程研究, 2023, 27(9): 1448-1454. |
[4] | 党 祎, 杜成砚, 姚红林, 袁能华, 曹 金, 熊 山, 张顶梅, 王 信. 激素型骨坏死与氧化应激[J]. 中国组织工程研究, 2023, 27(9): 1469-1476. |
[5] | 王 继, 张 敏, 杨中亚, 张 龙. 体力活动干预2型糖尿病肌少症的研究现状[J]. 中国组织工程研究, 2023, 27(8): 1272-1277. |
[6] | 聂晨晨, 苏凯奇, 高 静, 凡勇福, 阮晓迪, 袁 洁, 段昭远, 冯晓东. 环状RNA调控脑缺血发病的作用与机制[J]. 中国组织工程研究, 2023, 27(8): 1286-1291. |
[7] | 高 煜, 韩佳慧, 葛 新. 脊髓缺血再灌注损伤后的免疫炎性微环境[J]. 中国组织工程研究, 2023, 27(8): 1300-1305. |
[8] | 徐星星, 文超举, 孟茂花, 王勤英, 陈镜桥, 董 强. 口腔种植中的碳纳米材料[J]. 中国组织工程研究, 2023, 27(7): 1062-1070. |
[9] | 李 诚, 郑国爽, 蒯贤东, 于炜婷. 海藻酸盐支架修复关节软骨[J]. 中国组织工程研究, 2023, 27(7): 1080-1088. |
[10] | 陈世崧, 刘晓红, 徐志云. 人工生物瓣膜的研究现状及展望[J]. 中国组织工程研究, 2023, 27(7): 1096-1102. |
[11] | 史业弘, 王 成, 陈世玖. 小口径人工血管的早期血栓形成与预防[J]. 中国组织工程研究, 2023, 27(7): 1110-1116. |
[12] | 唐昊天, 廖荣东, 田 京. 压电材料修复骨缺损的应用及设计思路[J]. 中国组织工程研究, 2023, 27(7): 1117-1125. |
[13] | 刘文涛, 冯兴超, 杨 毅, 白生宾. M2型巨噬细胞外泌体诱导骨髓间充质干细胞的成骨分化[J]. 中国组织工程研究, 2023, 27(6): 840-845. |
[14] | 龙燕鸣, 谢梦生, 黄加洁, 薛文利, 荣 慧, 李晓捷. 酪蛋白激酶2相互作用蛋白1调控骨质疏松大鼠骨髓间充质干细胞的成骨能力[J]. 中国组织工程研究, 2023, 27(6): 878-882. |
[15] | 李启程, 邓 进, 付小洋, 韩 娜. 骨髓间充质干细胞来源外泌体对成肌细胞缺氧状态的影响[J]. 中国组织工程研究, 2023, 27(6): 853-859. |
1.1.7 检索策略 PubMed 数据库检索策略见图1,中文数据库检索策略见图2。
1.1.8 检索文献量 检索出中文文献180篇,英文文献469篇。
1.4 质量评估及数据提取 计算机初检得到中文文献180篇,英文文献469篇,经资料收集者互相评估纳入文献的有效性和适用性,通过阅读文题和摘要进行初步筛选;排除中英文文献重复性研究,以及内容不相关的文献,最后纳入中英文文献共97篇进行综述。文献检索流程见图3。
#br#
文题释义:
骨髓间充质干细胞:是存在于骨髓中具备多向分化能力的多能干细胞,具有来源丰富、培养简单、分化速度快、低排斥性等优势,常作为修复神经系统损伤和基因工程的理想种子细胞。中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程
目前研究中药联合骨髓间充质干细胞调控脑缺血再灌注损伤后血脑屏障机制进展用类文章并不多,多数主要以血脑屏障生理病理机制为出发点,从细胞结构、连接结构、神经炎症、相关因子以及血管生成等方面为切入点探求具体信号通路。此外目前多数研究致力于提高骨髓间充质干细胞及其衍生的细胞外囊泡克服并高效通过血脑屏障的能力,但目前研究较少。然而血脑屏障机制复杂,两者联合治疗相互关联的信号通路将成为未来研究发展的趋势。
中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||